What the Morpheus8 body applicator is
Morpheus8 body work runs on applicators designed for deeper tissue access than the face-focused configurations. The original gen-1 Morpheus8 Body (Blue) applicator and the gen-2 Burst Deep and 90 Applicator are listed in AccessGUDID under InMode Ltd. as the body-oriented members of the family. The FDA cleared the Morpheus8 90 Applicator under 510(k) K240017 (June 13, 2024) with indications language that explicitly covers contraction of soft tissue in dermatological procedures. The K192695 maximum cleared depth is 4.0 mm; deeper depths cited in marketing literature should be verified per specific applicator generation against current FDA documentation.
The K240017 clearance: contraction of soft tissue
The June 2024 clearance is the regulatory anchor for current Morpheus8 body work. The FDA listing for K240017 covers the InMode System with the Morpheus8 90 Applicator, classified as a Class II device under 21 CFR 878.4400 with Product Code GEI. The clearance was issued to InMode Ltd. (Yokneam, Israel) and lists the device as prescription per 21 CFR 801 Subpart D. The broader brand context and the K192695 baseline sit in the Morpheus8 device overview. The published indications for use are:
The InMode System with the Morpheus8 90 Applicator is intended for use in dermatological procedures where coagulation/contraction of soft tissue or hemostasis is needed. At higher energy levels greater than 62 mJ/pin, the use of the Morpheus8 90 Applicator is limited to Skin Types I-IV.
The language is broader than the K192695 indications, which cover electrocoagulation and hemostasis in dermatologic and general surgical procedures. The K240017 addition of "coagulation/contraction of soft tissue" creates a separate cleared purpose alongside the original electrocoagulation and hemostasis indication. The 510(k) Summary section for K240017 was not available in the primary source for this article, so the specific predicate identification was not verified here; the natural candidate is K192695, but that pairing was not confirmed against the K240017 Summary directly.
The 8 mm depth claim and what the FDA actually cleared
InMode marketing literature describes a Body Applicator with treatment depths up to 8 mm. The FDA 510(k) K192695 Summary lists a maximum treatment depth of 4.0 mm for the InMode System with the Morpheus8 (Fractora) Applicators, with the T tip head fixed at 0.5 mm. K240017 covers the 90 Applicator, but its Summary section was not available for this article, so the 8 mm figure cannot be cross-referenced against a specific cleared depth in the primary source here.
The honest framing for a procurement decision is that the 8 mm depth claim is a marketing figure that should be verified per specific applicator generation against the relevant FDA 510(k) summary or current device labeling. Pinova does not have primary source confirmation for an 8 mm cleared depth as of this writing. Clinics treating deeper-tissue cases under K240017 should use the cleared 4.0 mm specification from K192695 as the documented reference until the applicator-specific depth is verified against an authoritative FDA source.
Body applicator family: Body (Blue), Burst Deep, 90 Applicator
Three reusable applicators in the Morpheus8 family are positioned for body-oriented work, spread across the two product generations. The Body (Blue) applicator dates to the gen-1 product line (catalog series AG6091xx) and uses gen-1 tip configurations. Burst Deep and the 90 Applicator belong to the gen-2 product line (catalog series AG6130xx and AG6131xx) and use gen-2 tip families. The table below summarizes the catalog identifiers and the FDA reference each applicator currently carries in AccessGUDID under InMode Ltd.
| Applicator | Generation | Catalog # | Primary UDI-DI | FDA reference |
|---|---|---|---|---|
| Morpheus8 Body (Blue) | gen-1 | AG609126A | 07290016633672 | GUDID listing under InMode Ltd.; 510(k) intended use not verified in primary source for this article |
| Morpheus8 Burst Deep Applicator | gen-2 | AG613056A | 07290019863137 | GUDID listing under InMode Ltd.; clearance language for Burst submissions not reviewed in primary source for this article |
| Morpheus8 90 Applicator | gen-2 | AG613133A | 07290019863205 | K240017 (cleared June 13, 2024) |
GUDID submissions for the Morpheus8 Burst Applicator (the closely related gen-2 applicator on which the Burst Deep variant is built) reference K221571, K231790, K251254, and K251632, but the clearance language for those submissions was not reviewed in the primary source for this article. The Burst Deep listing references its own GUDID record under InMode Ltd. without a verified standalone summary in this round of research. SKU-level tip catalog detail for both gen-1 and gen-2 body applicators sits in the Morpheus8 tips and applicators article.
Common body treatment areas in clinical practice
Clinics commonly apply Morpheus8 body work to areas where dermal and sub-dermal tissue contouring is the clinical goal. The abdomen is the most frequently referenced area, including the lower abdomen following pregnancy or weight loss and the upper abdomen, where mild laxity sits over the rectus. The flanks and the lateral torso are routinely treated alongside the abdomen. Other areas commonly carried into a body-treatment protocol include the inner arms, the bra line, the inner thighs, the knees, and the posterior body where laxity follows weight changes. Some clinics also apply body-oriented applicators to jawline transitions and the décolletage, where the tissue profile sits between face and body work.
Each area carries its protocol considerations around depth setting, energy per pin, tip configuration, and pass count. Suitability for any specific case is determined by the treating practitioner and reflects skin type, tissue profile, prior history, and treatment goals. The decisions on which areas to add to a clinic's Morpheus8 portfolio sit alongside training and equipment investment decisions, not with the device specification alone. For broader category context, see the RF microneedling tips and cartridges catalog.
Why a clinic adds a body applicator to a face-only RF microneedling portfolio
Extending a Morpheus8 platform from face-only into body work changes both the case mix and the equipment economics. A face-only practice tends to draw on the 12-pin, 24-pin, and T-tip configurations and runs short-duration sessions on small treatment areas. Adding the Body (Blue) applicator at the gen-1 platform level or stepping up to a gen-2 platform that supports Burst Deep and the 90 Applicator expands the case profile into longer body sessions on larger treatment areas, which changes chair time per case and consumables draw per session.
The platform amortization argument is the second piece. The InMode, EmPowerRF, or Envision system that carries the Morpheus8 face applicator is the same platform that carries the body applicator, so the practice already absorbs the capital cost. Adding the body applicator extends the platform's contribution per dollar of original capital outlay. Consumables economics shift: body sessions typically draw on higher-pin-count tips and may use more tips per session than face work, which moves the per-session consumable cost upward but also typically pairs with higher patient-facing pricing for the body case. The three-layer cost decomposition (machine, consumables, operational) is structured in the Morpheus8 cost framework for clinics, and the comparison across modalities (HIFU, monopolar RF, ablative laser) sits in the Morpheus8 comparison hub.
Energy per pin, depth, and skin types: body protocol implications
The depth range a clinic can run with Morpheus8 body work follows from the applicator and the tip in use. Under K192695 the cleared maximum is 4.0 mm; the T tip is fixed at 0.5 mm. The 90 Applicator under K240017 is positioned for soft tissue contraction in dermatological procedures, but the applicator-specific depth specification was not verified in primary source for this article. Marketing literature places body applicator depths up to 8 mm; that figure is a manufacturer claim, not a verified-here FDA specification.
The energy per pin variable carries the same skin type constraint across applicators. K192695 and K240017 both restrict use above 62 mJ per pin to skin types I-IV. The body context tends to widen the Fitzpatrick mix of patients a clinic sees compared to face-only practices, which makes the energy ceiling protocol relevant rather than abstract. The treating practitioner decides which combination of applicator, tip configuration, depth setting, energy per pin, and pass count is appropriate for the case. Compatibility is based on industry-standard usage and clinical experience.
Used and refurbished body applicators: what to verify
The used market for Morpheus8 body applicators is active across both generations. Body (Blue) units appear on older InMode platforms; Burst Deep and 90 Applicator units appear on gen-2 platforms, including EmPowerRF and Envision configurations. Verification work for a used body applicator covers the catalog number and serial against the AccessGUDID listing under InMode Ltd., the FDA 510(k) status against the listed product codes, and the original configuration of the applicator. Modified or unlabeled equipment falls outside the cleared envelope and was specifically called out in the FDA's 2025 safety communication on RF microneedling. The device and equipment article in this series goes into platform selection, marketplace risks, and vendor verification in more depth.
Professionally sourced Morpheus8 body tips: how Pinova carries them
Pinova carries professionally sourced Morpheus8 tips for body applicators, alongside the face-oriented tip configurations. Inventory covers active gen-1 and gen-2 tip families that pair with the body-oriented applicators discussed above. Verification against the specific applicator generation in use is the responsibility of the buying clinic. Browse the InMode Morpheus8 Tips collection for current SKUs, pin counts, and packaging.
Frequently asked questions
What is the Morpheus8 body applicator?
"Morpheus8 body applicator" refers to the body-oriented applicators in the Morpheus8 family. Three are commonly grouped under that label: the Body (Blue) applicator from the gen-1 catalog series, and the Burst Deep applicator and 90 Applicator from the gen-2 catalog series. All three are reusable applicators that take single-use Morpheus8 tips, and all are listed in AccessGUDID under InMode Ltd.
What depth does Morpheus8 reach?
Under FDA 510(k) K192695, the maximum cleared treatment depth for the InMode System with the Morpheus8 (Fractora) Applicators is 4.0 mm, with the T tip head fixed at 0.5 mm. K240017 covers the 90 Applicator for coagulation or contraction of soft tissue, but the applicator-specific cleared depth was not verified in the primary source for this article. InMode marketing literature describes a Body Applicator with treatment depths up to 8 mm; that figure should be verified per applicator generation against current FDA documentation before being relied on for clinical decisions.
Can Morpheus8 be used on the stomach or abdomen?
Yes, the abdomen is one of the most commonly treated areas with Morpheus8 body applicators in clinical practice. The K240017 indications for the 90 Applicator cover dermatological procedures where coagulation or contraction of soft tissue is needed, which aligns with the clinical goal of abdominal soft-tissue work. Suitability for any specific case, including treatment area, depth setting, and energy per pin, is determined by the treating practitioner.
What is the difference between Morpheus8 face and Morpheus8 body?
The main difference is the applicator. Face-oriented work typically uses the 12-pin, 24-pin, or T-tip configurations on the standard Morpheus8 Applicator. Body-oriented work uses the Body (Blue) applicator in the gen-1 line or the Burst Deep and 90 Applicator in the gen-2 line, with higher-pin-count tips and deeper protocols. The cleared depth range and the Skin Type constraints in the FDA labeling apply across both applications.
